サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：解剖病理学の市場シェア、規模、動向、業界分析：製品別、用途別、最終用途別、地域別、セグメント別予測（2022年～2030年）
市場調査レポート
商品コード
1078346

解剖病理学の市場シェア、規模、動向、業界分析：製品別、用途別、最終用途別、地域別、セグメント別予測（2022年～2030年）

Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; By Application ; By End-Use, By Region; Segment Forecast, 2022 - 2030
出版日: | 発行: Polaris Market Research | ページ情報: 英文 112 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
解剖病理学の市場シェア、規模、動向、業界分析：製品別、用途別、最終用途別、地域別、セグメント別予測（2022年～2030年）
出版日: 2022年04月05日
発行: Polaris Market Research
ページ情報: 英文 112 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の解剖病理学の市場規模は、2030年までに655億4,000万米ドルに達すると予測されています。

当レポートでは、世界の解剖病理学市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、製品別・用途別・最終用途別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 前提条件
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データソース
    • 一次資料
    • 二次資料

第4章 世界の解剖病理学市場の洞察

  • 業界のスナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力（中）
    • 新規参入者の脅威(低）
    • 買い手の交渉力（中）
    • 代替の脅威（中）
    • 既存企業間の競争（高）
  • PESTEL分析
  • 業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の解剖病理学市場：製品別

  • 主な調査結果
  • イントロダクション
    • 製品別（2018年～2030年）
  • 機器
    • 機器別、地域別（2018年～2030年）
    • ミクロトーム・クライオスタット
    • ティッシュプロセッサー
    • 自動染色装置
    • ホールスライドイメージング（WSI）スキャナー
    • その他の製品
  • 消耗品
    • 消耗品別、地域別（2018年～2030年）
    • 試薬・抗体
    • プローブ・キット
    • その他
  • サービス
    • サービス別、地域別（2018年～2030年）

第6章 世界の解剖病理学市場：用途別

  • 主な調査結果
  • イントロダクション
    • 用途別（2018年～2030年）
  • 疾患診断
    • 疾患診断別、地域別（2018年～2030年）
  • 創薬開発
    • 創薬開発別、地域別（2018年～2030年）
  • その他
    • 地域別（2018年～2030年）

第7章 世界の解剖病理学市場：最終用途別

  • 主な調査結果
  • イントロダクション
    • 最終用途別（2018年～2030年）
  • 病院
    • 病院別、地域別（2018年～2030年）
  • 研究所
    • 研究所別、地域別（2018年～2030年）
  • 診断研究所
    • 診断研究所別、地域別（2018年～2030年）
  • その他
    • 地域別（2018年～2030年）

第8章 世界の解剖病理学市場：地域別

  • 主な調査結果
  • イントロダクション
    • 市場評価：地域別（2018年～2030年）
  • 北米
    • 製品別（2018年～2030年）
    • 最終用途別（2018年～2030年）
    • 用途別（2018年～2030年）
    • 米国
    • カナダ
  • 欧州
    • 製品別（2018年～2030年）
    • 最終用途別（2018年～2030年）
    • 用途別（2018年～2030年）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • オーストリア
  • アジア太平洋
    • 製品別（2018年～2030年）
    • 最終用途別（2018年～2030年）
    • 用途別（2018年～2030年）
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 製品別（2018年～2030年）
    • 最終用途別（2018年～2030年）
    • 用途別（2018年～2030年）
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • 製品別（2018年～2030年）
    • 最終用途別（2018年～2030年）
    • 用途別（2018年～2030年）
    • メキシコ
    • ブラジル
    • アルゼンチン

第9章 競合情勢

  • 事業拡張・企業買収の分析
    • 事業拡張
    • 企業買収
  • パートナーシップ/コラボレーション/契約/展示会

第10章 企業プロファイル

  • Abcam plc.
  • Agilent Technologies
  • Amos Scientific Pty Ltd.
  • Beckton
  • Bio SB
  • BioGenex
  • Bright Instruments
  • Cardinal Health
  • Cell Signaling Technology, Inc.
  • CellPath Ltd.
  • Danaher Corporation
  • Diapath S.p.A
  • Dickson and Company
  • F. Hoffmann-La Roche AG
  • Histo-Line Laboratories
  • Hologic, Inc.
  • Jinhua Yidi Medical Equipment Co., Ltd.
  • Laboratory Corporation of America Holdings
  • Lupetec
  • Medimeas
  • MEDITE Medical GmbH
  • Merck KGaA
  • MICROS AUSTRIA
  • Milestone Medical
  • NeoGenomics Laboratories, Inc
  • PHC Holdings Corporation
  • Quest Diagnostics Incorporated
  • R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
  • Sakura Finetek
  • SLEE medical GmbH
図表

List of Tables

  • Table 1 Global Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 2 Global Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 3 Global Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 4 Anatomic Pathology Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 5 North America: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 6 North America: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 7 North America: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 8 U.S.: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 9 U.S.: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 11 Canada: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 12 Canada: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 13 Canada: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 14 Europe: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 15 Europe: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 16 Europe: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 17 UK: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 18 UK: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 19 UK: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 20 France: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 21 France: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 22 France: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 26 Italy: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 27 Italy: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 28 Italy: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 29 Spain: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 30 Spain: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 31 Spain: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 32 Netherlands: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 33 Netherlands: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 34 Netherlands: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 35 Austria: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 36 Austria: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 37 Austria: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 41 China: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 42 China: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 43 China: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 44 India: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 45 India: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 46 India: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 47 Malaysia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 48 Malaysia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 49 Malaysia: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 50 Japan: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 51 Japan: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 52 Japan: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 53 Indonesia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 54 Indonesia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 55 Indonesia: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 56 South Korea: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 57 South Korea: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 58 South Korea: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 64 Saudi Arabia: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 65 UAE: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 66 UAE: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 67 UAE: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 68 Israel: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 69 Israel: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 70 Israel: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 71 South Africa: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 72 South Africa: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 73 South Africa: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 74 Latin America: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 75 Latin America: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 76 Latin America: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 77 Mexico: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 78 Mexico: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 79 Mexico: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 80 Brazil: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 81 Brazil: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 83 Argentina: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • Table 84 Argentina: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • Table 85 Argentina: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)

List of Figures

  • Figure 1. Global Anatomic Pathology Market, 2018 - 2030 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Anatomic Pathology Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Anatomic Pathology Market, by Product, 2021 & 2030 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Anatomic Pathology Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 12. Anatomic Pathology Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Figure 13. Strategic Analysis - Anatomic Pathology Market
目次
Product Code: PM2253

The global anatomic pathology market size is expected to reach USD 65.54 billion by 2030, according to a new study by Polaris Market Research. The report "Anatomic Pathology Market Share, Size, Trends, Industry Analysis Report, By Product; By Application (Disease Diagnosis, Drug Discovery and Development, Others); By End-Use (Hospitals, Research Laboratories, Diagnostic Laboratories, Others), By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global industry is expected to increase rapidly due to the growing focus on customized care and a large number of supporting programs and training modules provided by the government. The geriatric population is rapidly growing, as is the incidence rate of cancer and other chronic disorders. The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Modern anatomic pathology technology is becoming more widely used because of the significant rise in cancer cases.

The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Because the elderly are more susceptible to numerous illnesses, this demographic trend is expected to significantly increase the prevalence of several chronic diseases, including cancer, worldwide.

Furthermore, rising awareness and increased patient pool in developing countries propel the industry forward. Additionally, the industry is being driven by an increase in healthcare expenditure and the use of biomarkers during illness diagnosis.

Over the projected period, the drug discovery and development segment is expected to increase at a profitable rate. During preclinical studies, pathologists' tissue analysis provides pharmaceutical companies with a wide range of information. Moreover, the biologic's manufacturing service is also expected to register significant growth in the overall industry. This is due to the robust pipeline of new biological drugs due to the growing commercial success of biopharma companies across developed and developing economies paving the segment's growth.

Agilent Technologies, Abcam plc, Amos Scientific Pty Ltd., Bio SB, BioGenex, Bright Instruments, Cell Signaling Technology, Inc., Beckton, CellPath Ltd., Danaher Corporation, Diapath S.p.A, Dickson and Company, Cardinal Health, F. Hoffmann-La Roche AG, Hologic, Inc., Jinhua Yidi Medical Equipment Co., Ltd., Histo-Line Laboratories, Laboratory Corporation of America Holdings, Lupetec, Medimeas, Merck KGaA, MICROS AUSTRIA, Milestone Medical, NeoGenomics Laboratories, Inc., MEDITE Medical GmbH, Quest Diagnostics Incorporated, R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED, PHC Holdings Corporation, Sakura Finetek, and SLEE medical GmbH are some of the major players in the market.

In December 2021, Quest Diagnostics Incorporated introduced the liquid biopsy-based Target Selector NGS Lung Panel test. In October 2021, Roche partnered with PathAI, a global leader in artificial intelligence (AI)-based technologies. The firms will collaborate on pathologists' embedded image analysis workflow as part of the development and distribution arrangement.

Polaris Market Research has segmented the anatomic pathology market report based on product, application, end-use, and region:

Anatomic Pathology, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Instruments

Microtomes & Cryostat

Tissue Processors

Automatic Stainers

Whole Slide Imaging (WSI) Scanners

Other Products

Consumables

Reagents & Antibodies

Probes & Kits

Others

Services

Anatomic Pathology, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Disease Diagnosis

Drug Discovery and Development

Others

Anatomic Pathology, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Research Laboratories

Diagnostic Laboratories

Others

Anatomic Pathology, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

Italy

France

Spain

Austria

Netherlands

Asia Pacific

China

Japan

India

Indonesia

Malaysia

South Korea

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Israel

Saudi Arabia

South Africa

UAE

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Anatomic Pathology Market Insights

  • 4.1. Anatomic Pathology - Industry Snapshot
  • 4.2. Anatomic Pathology Market Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Restraints and Challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Anatomic Pathology Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Anatomic Pathology Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
  • 5.3. Instruments
    • 5.3.1. Global Anatomic Pathology Market, by Instruments, by Region, 2018 - 2030 (USD Billion)
    • 5.3.2. Microtomes & Cryostat
      • 5.3.2.1. Global Anatomic Pathology Market, by Microtomes & Cryostat, by Region, 2018 - 2030 (USD Billion)
    • 5.3.3. Tissue Processors
      • 5.3.3.1. Global Anatomic Pathology Market, by Tissue Processors, by Region, 2018 - 2030 (USD Billion)
    • 5.3.4. Automatic Stainers
      • 5.3.4.1. Global Anatomic Pathology Market, by Automatic Stainers, by Region, 2018 - 2030 (USD Billion)
    • 5.3.5. Whole Slide Imaging (WSI) Scanners
      • 5.3.5.1. Global Anatomic Pathology Market, by Whole Slide Imaging (WSI) Scanners, by Region, 2018 - 2030 (USD Billion)
    • 5.3.6. Other Products
      • 5.3.6.1. Global Anatomic Pathology Market, by Other Products, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Consumables
    • 5.4.1. Global Anatomic Pathology Market, by Consumables, by Region, 2018 - 2030 (USD Billion)
    • 5.4.2. Reagents & Antibodies
      • 5.4.2.1. Global Anatomic Pathology Market, by Reagents & Antibodies, by Region, 2018 - 2030 (USD Billion)
    • 5.4.3. Probes & Kits
      • 5.4.3.1. Global Anatomic Pathology Market, by Probes & Kits, by Region, 2018 - 2030 (USD Billion)
    • 5.4.4. Others
      • 5.4.4.1. Global Anatomic Pathology Market, by Others, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Services
    • 5.5.1. Global Anatomic Pathology Market, by Services, by Region, 2018 - 2030 (USD Billion)

6. Global Anatomic Pathology Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • 6.3. Disease Diagnosis
    • 6.3.1. Global Anatomic Pathology Market, by Disease Diagnosis, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Drug Discovery and Development
    • 6.4.1. Global Anatomic Pathology Market, by Drug Discovery and Development, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Anatomic Pathology Market, by Others, by Region, 2018 - 2030 (USD Billion)

7. Global Anatomic Pathology Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Anatomic Pathology Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Research Laboratories
    • 7.4.1. Global Anatomic Pathology Market, by Research Laboratories, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Diagnostic Laboratories
    • 7.5.1. Global Anatomic Pathology Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Anatomic Pathology Market, by Others, by Region, 2018 - 2030 (USD Billion)

8. Global Anatomic Pathology Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Anatomic Pathology Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Anatomic Pathology Market - North America
    • 8.3.1. North America: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.3.4. Anatomic Pathology Market - U.S.
      • 8.3.4.1. U.S.: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.3.5. Anatomic Pathology Market - Canada
      • 8.3.5.1. Canada: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4. Anatomic Pathology Market - Europe
    • 8.4.1. Europe: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.4. Anatomic Pathology Market - UK
      • 8.4.4.1. UK: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.5. Anatomic Pathology Market - France
      • 8.4.5.1. France: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.6. Anatomic Pathology Market - Germany
      • 8.4.6.1. Germany: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.7. Anatomic Pathology Market - Italy
      • 8.4.7.1. Italy: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.8. Anatomic Pathology Market - Spain
      • 8.4.8.1. Spain: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.9. Anatomic Pathology Market - Netherlands
      • 8.4.9.1. Netherlands: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.10. Anatomic Pathology Market - Austria
      • 8.4.10.1. Austria: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Austria.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Austria: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5. Anatomic Pathology Market - Asia Pacific
    • 8.5.1. Asia Pacific: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.4. Anatomic Pathology Market - China
      • 8.5.4.1. China: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.5. Anatomic Pathology Market - India
      • 8.5.5.1. India: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.6. Anatomic Pathology Market - Malaysia
      • 8.5.6.1. Malaysia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.7. Anatomic Pathology Market - Japan
      • 8.5.7.1. Japan: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.8. Anatomic Pathology Market - Indonesia
      • 8.5.8.1. Indonesia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.9. Anatomic Pathology Market - South Korea
      • 8.5.9.1. South Korea: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6. Anatomic Pathology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.4. Anatomic Pathology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.5. Anatomic Pathology Market - UAE
      • 8.6.5.1. UAE: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.6. Anatomic Pathology Market - Israel
      • 8.6.6.1. Israel: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.7. Anatomic Pathology Market - South Africa
      • 8.6.7.1. South Africa: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
  • 8.7. Anatomic Pathology Market - Latin America
    • 8.7.1. Latin America: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.4. Anatomic Pathology Market - Mexico
      • 8.7.4.1. Mexico: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.5. Anatomic Pathology Market - Brazil
      • 8.7.5.1. Brazil: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.6. Anatomic Pathology Market - Argentina
      • 8.7.6.1. Argentina: Anatomic Pathology Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Anatomic Pathology Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Anatomic Pathology Market, by Application, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abcam plc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amos Scientific Pty Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Beckton
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bio SB
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. BioGenex
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Bright Instruments
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Cardinal Health
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Cell Signaling Technology, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. CellPath Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Danaher Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Diapath S.p.A
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Dickson and Company
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. F. Hoffmann-La Roche AG
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Histo-Line Laboratories
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Hologic, Inc.
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Jinhua Yidi Medical Equipment Co., Ltd.
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Laboratory Corporation of America Holdings
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
  • 10.19. Lupetec
    • 10.19.1. Company Overview
    • 10.19.2. Financial Performance
    • 10.19.3. Product Benchmarking
    • 10.19.4. Recent Development
  • 10.20. Medimeas
    • 10.20.1. Company Overview
    • 10.20.2. Financial Performance
    • 10.20.3. Product Benchmarking
    • 10.20.4. Recent Development
  • 10.21. MEDITE Medical GmbH
    • 10.21.1. Company Overview
    • 10.21.2. Financial Performance
    • 10.21.3. Product Benchmarking
    • 10.21.4. Recent Development
  • 10.22. Merck KGaA
    • 10.22.1. Company Overview
    • 10.22.2. Financial Performance
    • 10.22.3. Product Benchmarking
    • 10.22.4. Recent Development
  • 10.23. MICROS AUSTRIA
    • 10.23.1. Company Overview
    • 10.23.2. Financial Performance
    • 10.23.3. Product Benchmarking
    • 10.23.4. Recent Development
  • 10.24. Milestone Medical
    • 10.24.1. Company Overview
    • 10.24.2. Financial Performance
    • 10.24.3. Product Benchmarking
    • 10.24.4. Recent Development
  • 10.25. NeoGenomics Laboratories, Inc
    • 10.25.1. Company Overview
    • 10.25.2. Financial Performance
    • 10.25.3. Product Benchmarking
    • 10.25.4. Recent Development
  • 10.26. PHC Holdings Corporation
    • 10.26.1. Company Overview
    • 10.26.2. Financial Performance
    • 10.26.3. Product Benchmarking
    • 10.26.4. Recent Development
  • 10.27. Quest Diagnostics Incorporated
    • 10.27.1. Company Overview
    • 10.27.2. Financial Performance
    • 10.27.3. Product Benchmarking
    • 10.27.4. Recent Development
  • 10.28. R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
    • 10.28.1. Company Overview
    • 10.28.2. Financial Performance
    • 10.28.3. Product Benchmarking
    • 10.28.4. Recent Development
  • 10.29. Sakura Finetek
    • 10.29.1. Company Overview
    • 10.29.2. Financial Performance
    • 10.29.3. Product Benchmarking
    • 10.29.4. Recent Development
  • 10.30. SLEE medical GmbH
    • 10.30.1. Company Overview
    • 10.30.2. Financial Performance
    • 10.30.3. Product Benchmarking
    • 10.30.4. Recent Development